Geneos Wealth Management Inc. Exact Sciences Corp Transaction History

Geneos Wealth Management Inc.

$2.6 Billion
Q3 2024

A detailed history of Geneos Wealth Management Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 1,193 shares of EXAS stock, worth $58,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,193

Previous 926 28.83%

Holding current value

$58,850

Previous $39,000 107.69%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $11,328 - $18,911	267 Added 28.83%	1,193 $81,000
Q2 2024 Jul 23, 2024	SELL	$41.33 - $74.26 $247 - $445	-6 Reduced 0.64%	926 $39,000
Q1 2024 May 03, 2024	BUY	$56.27 - $73.77 $337 - $442	6 Added 0.65%	932 $64,000
Q4 2023 Jan 26, 2024	SELL	$59.06 - $75.72 $1,476 - $1,893	-25 Reduced 2.63%	926 $68,000
Q2 2023 Aug 08, 2023	SELL	$62.68 - $95.05 $2,005 - $3,041	-32 Reduced 3.26%	951 $89,000
Q4 2022 Jan 30, 2023	SELL	$30.35 - $53.15 $6,828 - $11,958	-225 Reduced 18.63%	983 $48,000
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $240,318 - $371,114	-7,517 Reduced 86.15%	1,208 $39,000
Q2 2022 Jul 22, 2022	BUY	$35.61 - $76.23 $5,341 - $11,434	150 Added 1.75%	8,725 $343,000
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $17,037 - $24,431	-296 Reduced 3.34%	8,575 $599,000
Q4 2021 Feb 09, 2022	SELL	$72.5 - $100.68 $6,960 - $9,665	-96 Reduced 1.07%	8,871 $690,000
Q3 2021 Nov 09, 2021	SELL	$90.24 - $124.05 $20,304 - $27,911	-225 Reduced 2.45%	8,967 $862,000
Q2 2021 Jul 08, 2021	SELL	$93.66 - $139.27 $48,703 - $72,420	-520 Reduced 5.35%	9,192 $1.13 Million
Q4 2020 May 19, 2021	BUY	$99.61 - $142.12 $42,433 - $60,543	426 Added 4.59%	9,712 $1.16 Million
Q3 2020 Sep 07, 2021	BUY	$72.92 - $102.01 $947 - $1,326	13 Added 0.14%	9,286 $907,000
Q2 2020 Sep 07, 2021	BUY	$55.75 - $92.75 $9,533 - $15,860	171 Added 1.88%	9,273 $750,000
Q1 2020 Sep 07, 2021	BUY	$37.9 - $104.44 $6,443 - $17,754	170 Added 1.9%	9,102 $527,000
Q2 2019 Sep 07, 2021	BUY	$89.51 - $118.04 $32,939 - $43,438	368 Added 4.3%	8,932 $1.05 Million
Q1 2019 Sep 07, 2021	SELL	$61.98 - $96.5 $12,396 - $19,300	-200 Reduced 2.28%	8,564 $741,000
Q4 2018 Sep 07, 2021	BUY	$56.04 - $82.66 $5,604 - $8,266	100 Added 1.15%	8,764 $536,000
Q3 2018 Sep 07, 2021	SELL	$48.29 - $80.6 $9,658 - $16,119	-200 Reduced 2.26%	8,664 $683,000
Q1 2018 Sep 07, 2021	BUY	$39.82 - $57.53 $31,577 - $45,621	793 Added 9.83%	8,864 $357,000
Q4 2017 Sep 07, 2021	SELL	$46.49 - $60.51 $8,228 - $10,710	-177 Reduced 2.15%	8,071 $424,000
Q3 2017 Sep 07, 2021	SELL	$37.05 - $47.12 $767,638 - $976,279	-20,719 Reduced 71.53%	8,248 $388,000
Q2 2017 Sep 07, 2021	BUY	N/A	19,789 Added 215.61%	28,967 $1.02 Million
Q1 2017 Sep 07, 2021	BUY	N/A	781 Added 9.3%	9,178 $216,000
Q4 2016 Sep 07, 2021	BUY	N/A	1,001 Added 13.53%	8,397 $112,000
Q3 2016 Sep 07, 2021	BUY	N/A	96 Added 1.32%	7,396 $137,000
Q2 2016 Sep 07, 2021	BUY	N/A	7,000 Added 2333.33%	7,300 $89,000
Q1 2016 Sep 07, 2021	BUY	N/A	300	300 $2,000

Others Institutions Holding EXAS

# of Institutions

671

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account

Geneos Wealth Management Inc. Exact Sciences Corp Transaction History